AllPennyStocks.com Pharma Stock Massively Bid Up Following New Product Announcement

Pharma Stock Massively Bid Up Following New Product Announcement

Pharma Stock Massively Bid Up Following New Product Announcement By: Dylan Sikes – AllPennyStocks.com News

Wednesday, May 28, 2025

A Pharmaceuticals company based out of Puerto Rico is turning heads so far during Wednesday’s premarket hours after the company introduced its new “BUZZ BOMB” pre-workout supplement and announced it expects to launch in Q3. 

Traders wasted no time buying up shares of Aspire Biopharma Holdings Inc. (Nasdaq:ASBP), with shares of the micro cap currently bid up at $.4001/share (+77.82%) leading up to the opening bell. It should be an exciting session for this stock!

Aspire Biopharma is developing next generation absorption of medicine that will have a significant impact on the opioid crisis. Our nano technology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract. Aspire's technology comes from a new mechanism of action (absorption pathway) which allows for instant absorption in the mouth. Benefits of "instant absorption" are to provide nearly instant treatment impact and also allows high dose absorption. Our technology can be applied to any number of proven drugs and supplements, such as analgesics, erectile dysfunction, and traumatic brain injury drugs.


Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Travel Tech Play Soars on a Bet on China's Inbound Tourism Reopening
A Nickel District in Northern Ontario Just Reached a Scale That Invites Sudbury Comparisons
When Gold Sets Records, the Lowest-Cost Ounces Win the Rerating
Most Popular
{{ index + 1 }}


Back to Top